Attana will present at Stora Aktiedagen on December 1

 Attana will participate at Aktiespararna's event Stora Aktiedagen at Sheraton Hotel in Stockholm on December 1 to give a presentation and answer questions.

The presentation will be20 minutes long and is followed by a Q&A of 10 minutes. More information about the presentation's content and link to the live broadcast of the event will be published in a later press release.

For more information, please contact:

Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com

Tags: